LONDON Patients in England will soon have faster access to promising new treatments under a designated fund announced by the National Health Service Wednesday, which is expected to be launched later in the year.
The Innovative Medicines Fund (IMF) will provide quick access to the latest technologies such as cell and gene therapies to treat rare diseases and is open to all therapeutic areas.
Just like the National Health Service s Cancer Drugs Fund, this scheme will let highly promising new therapies qualify for NHS England funding even though the true extent of their clinical benefits is uncertain. Over a period of time, typically two years, it would allow immediate access for patients while requiring the participating company to carry out further data collection on the drug’s benefits and harms.
NHS earmarks £340m for new medicines fund to fast-track innovative treatments
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
expert reaction to the annual statistics on the use of animals in scientific procedures in the UK for 2020
sciencemediacentre.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemediacentre.org Daily Mail and Mail on Sunday newspapers.
Rising to the challenge
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
Date Time
Share
Bold new life sciences vision sets path for UK to build on pandemic response and deliver life-changing innovations to patients
UK Life Sciences Vision sets 10-year strategy for sector to build on successes of COVID-19 response and accelerate delivery of innovations to patients
mission-led approach to solve some of the biggest healthcare problems of our generation, including cancer and dementia
launch of Life Sciences Investment Programme brings total amount of funding available to UK’s most promising life sciences companies to £1 billion
The remarkable response of the UK’s world class life sciences sector to COVID-19 will be used as a blueprint to accelerate the delivery of life-changing innovations to patients, as part of the government’s new UK Life Sciences Vision published today (Wednesday 7 July).